https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab

FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab

The approval of 2 denosumab biosimilars, Bildyos and Bilprevda, enhances access to affordable bone health treatments for patients.

administrator

Related Articles